Moving toward Laparoscopic Pyloromyotomy: An Initial Italian Experience and National Survey

S. Ceccanti,E. Mele,S. Frediani,D. Morgante,R. Iaconelli,N. Almenrader,M. Passariello,D. Cozzi

DOI: https://doi.org/10.1177/000313481307900938

2013-09-01

The American Surgeon

Abstract:

What problem does this paper attempt to address?

Prospects and Challenges of Bacteriophage Substitution for Antibiotics in Livestock and Poultry Production

Aoyu Jiang,Zixin Liu,Xiaokang Lv,Chuanshe Zhou,Tao Ran,Zhiliang Tan

DOI: https://doi.org/10.3390/biology13010028

2024-01-04

Biology

Abstract:The overuse and misuse of antibiotics in the livestock and poultry industry has led to the development of multi-drug resistance in animal pathogens, and antibiotic resistance genes (ARGs) in bacteria transfer from animals to humans through the consumption of animal products, posing a serious threat to human health. Therefore, the use of antibiotics in livestock production has been strictly controlled. As a result, bacteriophages have attracted increasing research interest as antibiotic alternatives, since they are natural invaders of bacteria. Numerous studies have shown that dietary bacteriophage supplementation could regulate intestinal microbial composition, enhance mucosal immunity and the physical barrier function of the intestinal tract, and play an important role in maintaining intestinal microecological stability and normal body development of animals. The effect of bacteriophages used in animals is influenced by factors such as species, dose, and duration. However, as a category of mobile genetic elements, the high frequency of gene exchange of bacteriophages also poses risks of transmitting ARGs among bacteria. Hence, we summarized the mechanism and efficacy of bacteriophage therapy, and highlighted the feasibility and challenges of bacteriophage utilization in farm animal production, aiming to provide a reference for the safe and effective application of bacteriophages as an antibiotic alternative in livestock and poultry.

biology
Bacteriophage therapy in aquaculture: current status and future challenges

Ruyin Liu,Ganghua Han,Zong Li,Shujuan Cun,Bin Hao,Jianping Zhang,Xinchun Liu

DOI: https://doi.org/10.1007/s12223-022-00965-6

2022-03-19

Folia Microbiologica

Abstract:The escalation of antibiotic resistance has revitalized bacteriophage (phage) therapy. Recently, phage therapy has been gradually applied in medicine, agriculture, food, and environmental fields due to its distinctive features of high efficiency, specificity, and environmental friendliness compared to antibiotics. Likewise, phage therapy also holds great promise in controlling pathogenic bacteria in aquaculture. The application of phage therapy instead of antibiotics to eliminate pathogenic bacteria such as Vibrio, Pseudomonas, Aeromonas, and Flavobacterium and to reduce fish mortality in aquaculture has been frequently reported. In this context, the present review summarizes and analyzes the current status of phage therapy in aquaculture, focusing on the key parameters of phage application, such as phage isolation, selection, dosage, and administration modes, and introducing the strategies and methods to boost efficacy and restrain the emergence of resistance. In addition, we discussed the human safety, environmental friendliness, and techno-economic practicability of phage therapy in aquaculture. Finally, this review outlines the current challenges of phage therapy application in aquaculture from the perspectives of phage resistance, phage-mediated resistance gene transfer, and effects on the host immune system.

microbiology,biotechnology & applied microbiology
Bacteriophage Therapy in Companion and Farm Animals

Laura Bianchessi,Giulia De Bernardi,Martina Vigorelli,Paola Dall’Ara,Lauretta Turin,Paola Dall'Ara

DOI: https://doi.org/10.3390/antibiotics13040294

2024-03-23

Antibiotics

Abstract:Bacteriophages, which are viruses with restricted tropism for bacteria, have been employed for over a century as antimicrobial agents; they have been largely abandoned in Western countries but are constantly used in Eastern European countries with the advent of antibiotics. In recent decades, the growing spread of multidrug-resistant bacteria, which pose a serious threat to worldwide public health, imposed an urgent demand for alternative therapeutic approaches to antibiotics in animal and human fields. Based on this requirement, numerous studies have been published on developing and testing bacteriophage-based therapy. Overall, the literature largely supports the potential of this perspective but also highlights the need for additional research as the current standards are inadequate to receive approval from regulatory authorities. This review aims to update and critically revise the current knowledge on the application of bacteriophages to treat bacterial-derived infectious diseases in animals in order to provide topical perspectives and innovative advances.

pharmacology & pharmacy,infectious diseases
Bacteriophages and its applications: an overview

Sonika Sharma,Soumya Chatterjee,Sibnarayan Datta,Rishika Prasad,Dharmendra Dubey,Rajesh Kumar Prasad,Mohan G Vairale

DOI: https://doi.org/10.1007/s12223-016-0471-x

2016-10-08

Folia Microbiologica

Abstract:Bacteriophages (or phages), the most abundant viral entity of the planet, are omni-present in all the ecosystems. On the basis of their unique characteristics and anti-bacterial property, phages are being freshly evaluated taxonomically. Phages replicate inside the host either by lytic or lysogenic mode after infecting and using the cellular machinery of a bacterium. Since their discovery by Twort and d’Herelle in the early 1900s, phage became an important agent for combating pathogenic bacteria in clinical treatments and its related research gained momentum. However, due to recent emergence of bacterial resistance on antibiotics, applications of phage (phage therapy) become an inevitable option of research. Phage particles become popular as a biotechnological tool and treatment of pathogenic bacteria in a range of applied areas. However, there are few concerns over the application of phage-based solutions. This review deals with the updated phage taxonomy (ICTV 2015 Release and subsequent revision) and phage biology and the recent development of its application in the areas of biotechnology, biosensor, therapeutic medicine, food preservation, aquaculture diseases, pollution remediation, and wastewater treatment and issues related with limitations of phage-based remedy.

microbiology,biotechnology & applied microbiology
Recent trends in the use of bacteriophages as replacement of antimicrobials against food-animal pathogens

Sana Zia,Khalid A. Alkheraije

DOI: https://doi.org/10.3389/fvets.2023.1162465

IF: 3.471

2023-05-25

Frontiers in Veterinary Science

Abstract:A major public health impact is associated with foodborne illnesses around the globe. Additionally, bacteria are becoming more resistant to antibiotics, which pose a global threat. Currently, many scientific efforts have been made to develop and implement new technologies to combat bacteria considering the increasing emergence of multidrug-resistant bacteria. In recent years, there has been considerable interest in using phages as biocontrol agents for foodborne pathogens in animals used for food production and in food products themselves. Foodborne outbreaks persist, globally, in many foods, some of which lack adequate methods to control any pathogenic contamination (like fresh produce). This interest may be attributed both to consumers' desire for more natural food and to the fact that foodborne outbreaks continue to occur in many foods. Poultry is the most common animal to be treated with phage therapy to control foodborne pathogens. A large number of foodborne illnesses worldwide are caused by Salmonella spp. and Campylobacter , which are found in poultry and egg products. Conventional bacteriophage-based therapy can prevent and control humans and animals from various infectious diseases. In this context, describing bacteriophage therapy based on bacterial cells may offer a breakthrough for treating bacterial infections. Large-scale production of pheasants may be economically challenging to meet the needs of the poultry market. It is also possible to produce bacteriophage therapy on a large scale at a reduced cost. Recently, they have provided an ideal platform for designing and producing immune-inducing phages. Emerging foodborne pathogens will likely be targeted by new phage products in the future. In this review article, we will mainly focus on the Bacteriophages (phages) that have been proposed as an alternative strategy to antibiotics for food animal pathogens and their use for public health and food safety.

veterinary sciences
A Concise Overview of Studies on Successful Real-World Applications of Bacteriophages in Aquaculture

Jin Woo Jun

DOI: https://doi.org/10.3390/v16121843

2024-11-28

Viruses

Abstract:Increasing antibiotic resistance poses an urgent global public health threat and a serious concern worldwide. Bacteriophage (phage) therapy has been identified as a promising alternative to antibiotics for treating bacterial diseases in both humans and animals. The excessive use of antibiotics in aquaculture is a major threat to sustainable aquaculture, promoting the spread of antibiotic resistance in the aquaculture environment and the contamination of aquaculture products with antibiotic residues. Consequently, interest in alternative approaches that reduce reliance on antibiotics has grown within the aquaculture sector. As a promising alternative, extensive phage research targeted at aquaculture has demonstrated the protective efficacy of phages against diseases in aquatic animals. Although numerous studies have employed in vitro models, research supported by in vivo experiments remains scarce. Without in vivo evidence, phage therapy cannot fulfill the requirements of aquaculturists. The first part of this review outlines the bacterial diseases severely affecting the health and survival of aquatic animals. The second part provides updates on phage applications for the therapy and prophylaxis of pathogenic bacterial infection in aquatic animals, including administration routes and key accomplishments. Therefore, this review provides insights into effective real-world phage biocontrol strategies that enable sustainable aquaculture.

virology
Bacteriophages as a potential substitute for antibiotics: A comprehensive review

Shruti O. Kushwaha,Santosh Kumar Sahu,Virendra Kumar Yadav,Mayuri C. Rathod,Dhaval Patel,Dipak Kumar Sahoo,Ashish Patel

DOI: https://doi.org/10.1002/cbf.4022

2024-04-26

Cell Biochemistry and Function

Abstract:Over the years, the administration of antibiotics for the purpose of addressing bacterial infections has become increasingly challenging due to the increased prevalence of antimicrobial resistance exhibited by various strains of bacteria. Multidrug‐resistant (MDR) bacterial species are rising due to the unavailability of novel antibiotics, leading to higher mortality rates. With these conditions, there is a need for alternatives in which phage therapy has made promising results. Phage‐derived endolysins, phage cocktails, and bioengineered phages are effective and have antimicrobial properties against MDR and extensively drug‐resistant strains. Despite these, it has been observed that phages can give antimicrobial activity to more than one bacterial species. Thus, phage cocktail against resistant strains provides broad spectrum treatment and magnitude of effectivity, which is many folds higher than antibiotics. Many commercially available endolysins such as Staphefekt SA.100, Exebacase (CF‐301), and N‐Rephasin®SAL200 are used in biofilm penetration and treating plant diseases. The role of CMP1 phage endolysin in transgenic tomato plants in preventing Clavibacter michiganensis infection and the effectiveness of phage in protecting Atlantic salmon from vibriosis have been reported. Furthermore, phage‐derived endolysin therapy, such as TSPphg phage exogenous treatment, can aid in disrupting cell walls, leading to bacterial cell lysis. As animals in aquaculture and slaughterhouses are highly susceptible to bacterial infections, effective phage therapy instead of antibiotics can help treat poultry animals, preserve them, and facilitate disease‐free trade. Using bioengineered phages and phage cocktails enhances the effectiveness by providing a broad spectrum of phages and target specificity. Research is currently being conducted on clinical trials to confirm the efficacy of engineered phages and phage cocktails in humans. Although obtaining commercial approval may be time‐consuming, it will be beneficial in the postantibiotic era. This review provides an overview of the significance of phage therapy as a potential alternative to antibiotics in combating resistant bacterial strains and its application to various fields and emphasizes the importance of safeguarding and ensuring treatment efficacy.

cell biology,biochemistry & molecular biology
Phage Therapy in Veterinary Medicine

Rosa Loponte,Ugo Pagnini,Giuseppe Iovane,Giuseppe Pisanelli

DOI: https://doi.org/10.3390/antibiotics10040421

2021-04-11

Antibiotics

Abstract:To overcome the obstacle of antimicrobial resistance, researchers are investigating the use of phage therapy as an alternative and/or supplementation to antibiotics to treat and prevent infections both in humans and in animals. In the first part of this review, we describe the unique biological characteristics of bacteriophages and the crucial aspects influencing the success of phage therapy. However, despite their efficacy and safety, there is still no specific legislation that regulates their use. In the second part of this review, we describe the comprehensive research done in the past and recent years to address the use of phage therapy for the treatment and prevention of bacterial disease affecting domestic animals as an alternative to antibiotic treatments. While in farm animals, phage therapy efficacy perspectives have been widely studied in vitro and in vivo, especially for zoonoses and diseases linked to economic losses (such as mastitis), in pets, studies are still few and rather recent.
Bacteriophage Lysins: Antibacterial Effects and Medical Application

CHEN Wei-qing,WANG Xiao-feng,WANG Pu,WU Min

DOI: https://doi.org/10.3321/j.issn:1003-3734.2009.10.008

2009-01-01

Abstract:In recent decades,drug-resistance of pathogenic bacteria resulting from antibiotics abuse has greatly threatened human health. Bacteriophage lysins as new therapeutics have begun to attract people's attention. Bacteriophage lysins are cell wall hydrolysing enzymes synthesized during late gene expression in the lytic cycle of phages multiplication; thereby they hydrolyze the peptidoglycan and enable the release of progeny phages. Studies have indicated that lysins can kill bacteria efficiently and specifically in vivo. In this article,new progress in the research of mechanism,structural characteristics,antibacterial activity of bacteriophage lysins,as well as recombinant lysins preparation by genetic engineering,were reviewed in combination with author's research work. As a new type of antimicrobial medicine,the research focus and application prospects of lysins in the future were discussed as well.
Bacteriophages and their potential for treatment of gastrointestinal diseases

Yi Duan,Ry Young,Bernd Schnabl

DOI: https://doi.org/10.1038/s41575-021-00536-z

2021-11-15

Abstract:Although bacteriophages have been overshadowed as therapeutic agents by antibiotics for decades, the emergence of multidrug-resistant bacteria and a better understanding of the role of the gut microbiota in human health and disease have brought them back into focus. In this Perspective, we briefly introduce basic phage biology and summarize recent discoveries about phages in relation to their role in the gut microbiota and gastrointestinal diseases, such as inflammatory bowel disease and chronic liver disease. In addition, we review preclinical studies and clinical trials of phage therapy for enteric disease and explore current challenges and potential future directions.

gastroenterology & hepatology
Framing the Future with Bacteriophages in Agriculture

Antonet Svircev,Dwayne Roach,Alan Castle

DOI: https://doi.org/10.3390/v10050218

2018-04-25

Viruses

Abstract:The ability of agriculture to continually provide food to a growing world population is of crucial importance. Bacterial diseases of plants and animals have continually reduced production since the advent of crop cultivation and animal husbandry practices. Antibiotics have been used extensively to mitigate these losses. The rise of antimicrobial resistant (AMR) bacteria, however, together with consumers’ calls for antibiotic-free products, presents problems that threaten sustainable agriculture. Bacteriophages (phages) are proposed as bacterial population control alternatives to antibiotics. Their unique properties make them highly promising but challenging antimicrobials. The use of phages in agriculture also presents a number of unique challenges. This mini-review summarizes recent development and perspectives of phages used as antimicrobial agents in plant and animal agriculture at the farm level. The main pathogens and their adjoining phage therapies are discussed.

virology
Thromboxane a2: biosynthesis and effects on platelets.

E. Granström,U. Diczfalusy,M. Hamberg,G. Hansson,C. Malmsten,B. Samuelsson

Abstract:
Phage and antibiotic combination therapy:feasibility and challenges

FENG Lu-yao,ZHU Xiao-fei,WU Zhong-wen,LI Lan-juan

DOI: https://doi.org/10.13381/j.cnki.cjm.202303020

2023-01-01

Abstract:Phage are viruses that specifically infect bacteria and have been used as antimicrobial agents since discovery.However, with the widespread use of antibiotics, phage therapy gradually faded into oblivion. At present, the emergence of antibiotic resistance （especially multi-drug resistance） seriously endangers the life and health of patients. Therefore, antibiotic resistance has become a global public health problem, which puts forward the necessity of finding new treatment methods. Long neglected in the West, phage therapy is regaining momentum. In this paper, we discussed some examples of phage and antibiotic combinations by examining a relatively large number of cases, at home and abroad, elaborated the feasibility of this dual therapy, and pointed out its challenges. In addition, we illustrated some possible mechanisms of the interaction between phages and antibiotics.
Exploring Bacteriophage Applications in Medicine and Beyond

Ahmed Elfadadny,Rokaia F. Ragab,Manar A. Abou Shehata,Medhat R. Elfadadny,Ahmed Farag,Ayman H. Abd El-Aziz,Hazim O. Khalifa

DOI: https://doi.org/10.3390/amh69030016

2024-07-08

Abstract:Bacteriophages, or phages, are microscopic viruses that specifically infect and replicate within bacterial hosts. Their unique ability to target and control bacterial populations makes them valuable tools with applications ranging from human medicine and agriculture and environmental management to biotechnology. In this comprehensive review, we explore the diverse and promising medical and non-medical applications of bacteriophages, highlighting their pivotal role across various niches. From safeguarding food production through pathogen control to their innovative utilization in wastewater treatment, bacteriophages prove to be versatile agents. To achieve applications of phages on a larger scale, it is necessary to make the legal framework more suitable and flexible, create special approval programs (e.g., for novel antimicrobial drugs), and promote targeted research and development activities on phages. Additionally, a more intensive exchange between academia, industry, regulatory authorities, and stakeholders in the health system should be pursued.
Bacteriophage Technology and Modern Medicine

Aa Haeruman Azam,Xin-Ee Tan,Srivani Veeranarayanan,Kotaro Kiga,Longzhu Cui

DOI: https://doi.org/10.3390/antibiotics10080999

2021-08-18

Antibiotics

Abstract:The bacteriophage (or phage for short) has been used as an antibacterial agent for over a century but was abandoned in most countries after the discovery and broad use of antibiotics. The worldwide emergence and high prevalence of antimicrobial-resistant (AMR) bacteria have led to a revival of interest in the long-forgotten antibacterial therapy with phages (phage therapy) as an alternative approach to combatting AMR bacteria. The rapid progress recently made in molecular biology and genetic engineering has accelerated the generation of phage-related products with superior therapeutic potentials against bacterial infection. Nowadays, phage-based technology has been developed for many purposes, including those beyond the framework of antibacterial treatment, such as to suppress viruses by phages, gene therapy, vaccine development, etc. Here, we highlighted the current progress in phage engineering technology and its application in modern medicine.

pharmacology & pharmacy,infectious diseases
Treating bacterial infections with bacteriophages in the 21st century

Christoffel J Opperman,Justyna M Wojno,Adrian J Brink

DOI: https://doi.org/10.4102/sajid.v37i1.346

2022-03-29

Abstract:Bacteriophages (phages) were discovered in the early part of the 20th century, and their ability to eliminate bacterial infections as bacterial viruses gathered interest almost immediately. Bacteriophage therapy was halted in the Western world due to inconclusive results in early experiments and the concurrent discovery of antibiotics. The spread of antibiotic-resistant bacteria has elicited renewed interest in bacteriophages as a natural alternative to conventional antibiotic therapy. Interest in the application of bacteriophages has also expanded to include the environment, such as wastewater treatment, agriculture and aquaculture. Although the complete phage is important in bacteriophage therapy, the focus is shifting to purified phage enzymes. These enzymes are an attractive option for pharmaceutical companies with their patent potential. They can be bio-engineered for enhanced adjuvant properties, such as a broadened spectrum of activity or binding capability. Enzymes also eliminate the concern that the prophage might integrate resistance genes into the bacterial genome. From a clinical perspective, the first randomised clinical controlled phage therapy trial was conducted with more pioneering phase I/II clinical studies on the horizon. In this opinion paper, the authors outline bacteriophages as naturally occurring bactericidal entities, their therapeutic potential against antibiotic-resistant bacteria and compare them to antibiotics. Their potential multipurpose application in the medical field is also addressed, including the use of bacteriophages for vaccination, and utilisation of the antimicrobial enzymes that they produce.
Biological foundations of successful bacteriophage therapy

Carola Venturini,Aleksandra Petrovic Fabijan,Alicia Fajardo Lubian,Stefanie Barbirz,Jonathan Iredell

DOI: https://doi.org/10.15252/emmm.202012435

2022-05-28

EMBO Molecular Medicine

Abstract:This comprehensive review discusses bacterium–phage interactions, antimicrobial potential of phages and research challenges that impact realization of the successful bacteriophage therapy. Bacteriophages (phages) are selective viral predators of bacteria. Abundant and ubiquitous in nature, phages can be used to treat bacterial infections (phage therapy), including refractory infections and those resistant to antibiotics. However, despite an abundance of anecdotal evidence of efficacy, significant hurdles remain before routine implementation of phage therapy into medical practice, including a dearth of robust clinical trial data. Phage–bacterium interactions are complex and diverse, characterized by co‐evolution trajectories that are significantly influenced by the environments in which they occur (mammalian body sites, water, soil, etc.). An understanding of the molecular mechanisms underpinning these dynamics is essential for successful clinical translation. This review aims to cover key aspects of bacterium–phage interactions that affect bacterial killing by describing the most relevant published literature and detailing the current knowledge gaps most likely to influence therapeutic success.

medicine, research & experimental
Unveiling the Impact of Antibiotics and Alternative Methods for Animal Husbandry: A Review

Chuen Xian Low,Loh Teng-Hern Tan,Nurul-Syakima Ab Mutalib,Priyia Pusparajah,Bey-Hing Goh,Kok-Gan Chan,Vengadesh Letchumanan,Learn-Han Lee

DOI: https://doi.org/10.3390/antibiotics10050578

2021-05-13

Antibiotics

Abstract:Since the 1950s, antibiotics have been used in the field of animal husbandry for growth promotion, therapy and disease prophylaxis. It is estimated that up to 80% of the antibiotics produced by the pharmaceutical industries are used in food production. Most of the antibiotics are used as feed additives at sub-therapeutic levels to promote growth. However, studies show the indiscriminate use of antibiotics has led to the emergence of multidrug-resistant pathogens that threaten both animal health and human health, including vancomycin-resistant Enterococcus (VRE), Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE). This scenario is further complicated by the slow progress in achieving scientific breakthroughs in uncovering novel antibiotics following the 1960s. Most of the pharmaceutical industries have long diverted research funds away from the field of antibiotic discovery to more lucrative areas of drug development. If this situation is allowed to continue, humans will return to the pre-antibiotics era and potentially succumb to huge health and economic consequences. Fortunately, studies investigating various alternatives to antibiotics use in livestock show promising results. These alternatives include the application of bacteriophages and phage derived peptidoglycan degrading enzymes, engineered peptides, egg yolk antibodies, probiotics, prebiotics and synbiotics, as well as quorum quenching molecules. Therefore, this review aims to discuss the use of growth-promoting antibiotics and their impact on livestock and provide insights on the alternative approaches for animal husbandry.
[Erythrocyte aggregation and clinical course stages of venous insufficiency of the legs].

F. Zuccarelli,A. Chabanel,A. Taccoen,M. Samama

Journal des Maladies Vasculaires

Abstract:A double vicious circle at the venule and capillary level had already been pointed out by J. Dormandy and G. Nash as a pathophysiologic mechanism of rheological disorders associated with venous insufficiency of the lower limbs. Afterwards, such disorders were found by many authors when ex vivo analysis were performed on venous insufficient patients. However the time of their onset and their evolution in the course of the disease remain unknown. We studied red cell aggregation and plasma fibrinogen in 67 patients depending on the evolutive stage: 1st stage: isolated functional disorders, 2nd stage: trunk varicose vein linked to ostial incompetence, 3rd stage: trunk varicose vein linked to ostial incompetence with chronic trophic skin changes. The results showed that red cell aggregation and fibrinogen values are increased with the severity of the diseases. The rheological parameters increase when compared to controls from the first stage. Within the studied population, we avoided skewed results due to age and fibrinogen level by covariance analysis. Therefore recorded differences were practically linked with erythrocyte aggregability. Thus, red cell aggregation appears to be both an aggravating factor and a severity marker of the disease, proving the relevance of a rheological treatment in the lower limb insufficiency.
Bacteriophages and their application in food safety

P. García,B. Martínez,J.M. Obeso,A. Rodríguez

DOI: https://doi.org/10.1111/j.1472-765x.2008.02458.x

2008-12-01

Letters in Applied Microbiology

Abstract:In recent years it has become widely recognized that bacteriophages have several potential applications in the food industry. They have been proposed as alternatives to antibiotics in animal health, as biopreservatives in food and as tools for detecting pathogenic bacteria throughout the food chain. Bacteriophages are viruses that only infect and lyse bacterial cells. Consequently, they display two unique features relevant in and suitable for food safety. Namely, their safe use as they are harmless to mammalian cells and their high host specificity that allows proper starter performance in fermented products and keeps the natural microbiota undisturbed. However, the recent approval of bacteriophages as food additives has opened the discussion about 'edible viruses'. In this review, we examine the promising uses of phages for the control of foodborne pathogens and the drawbacks on which more research is needed to further exploit these biological entities.

microbiology,biotechnology & applied microbiology

Moving toward Laparoscopic Pyloromyotomy: An Initial Italian Experience and National Survey

Prospects and Challenges of Bacteriophage Substitution for Antibiotics in Livestock and Poultry Production

Bacteriophage therapy in aquaculture: current status and future challenges

Bacteriophage Therapy in Companion and Farm Animals

Bacteriophages and its applications: an overview

Recent trends in the use of bacteriophages as replacement of antimicrobials against food-animal pathogens

A Concise Overview of Studies on Successful Real-World Applications of Bacteriophages in Aquaculture

Bacteriophages as a potential substitute for antibiotics: A comprehensive review

Phage Therapy in Veterinary Medicine

Bacteriophage Lysins: Antibacterial Effects and Medical Application

Bacteriophages and their potential for treatment of gastrointestinal diseases

Framing the Future with Bacteriophages in Agriculture

Thromboxane a2: biosynthesis and effects on platelets.

Phage and antibiotic combination therapy:feasibility and challenges

Exploring Bacteriophage Applications in Medicine and Beyond

Bacteriophage Technology and Modern Medicine

Treating bacterial infections with bacteriophages in the 21st century

Biological foundations of successful bacteriophage therapy

Unveiling the Impact of Antibiotics and Alternative Methods for Animal Husbandry: A Review

[Erythrocyte aggregation and clinical course stages of venous insufficiency of the legs].

Bacteriophages and their application in food safety